Associate Professor, Medicine, Brown University Program in Medicine
Pulmonology
Dr. James R. Klinger, MD
|
|
Give Review
James R. Klinger, MD practices Pulmonology. He went to medical school at Medical College of Wisconsin. Medical College of Wisconsin is ranked 54/62 in Research/PrimaryCare. He has 1 awards "CMS Meaningful Use Stage 1 Certification". James Klinger is a published doctor. He has 73 publications published. The most current publication "C-type natriuretic peptide expression and pulmonary vasodilation in hypoxia-adapted rats." He is registered with Medicare.
Publications
- Risk of Echocardiographic Pulmonary Hypertension in Individuals with Human Immunodeficiency Virus-Hepatitis C Virus Coinfection.
- Are Hemodynamics Surrogate Endpoints in Pulmonary Arterial Hypertension?
- Management of Acute Right Ventricular Failure in the Intensive Care Unit.
- Effects of dose and age on adverse events associated with tadalafil in the treatment of Pulmonary arterial hypertension.
- Induction of Pulmonary hypertensive changes by extracellular vesicles from monocrotaline-treated mice.
- Nitric Oxide Deficiency and Endothelial Dysfunction in Pulmonary Arterial Hypertension.
- Atrial Natriuretic Peptide Attenuates Agonist Induced Pulmonary Edema In Mice With Targeted Disruption of the Gene For Natriuretic Peptide Receptor-A.
- Partial anomalous Pulmonary venous return presenting with adult-onset Pulmonary hypertension.
- Initial Risk Assessment for Pulmonary Hypertension in Patients with COPD.
- Combination therapy for the treatment of Pulmonary arterial hypertension.
- Pulmonary Hypertension in a Stable Community-Based COPD Population.
- C-type natriuretic peptide does not attenuate the development of Pulmonary hypertension caused by hypoxia and VEGF receptor blockade.
- Bosentan attenuates right ventricular hypertrophy and fibrosis in normobaric hypoxia model of Pulmonary hypertension.
- Echocardiographic Evidence of Pulmonary Hypertension is Associated with Increased 1-year Mortality in Patients Admitted with Chronic Obstructive Pulmonary Disease.
- Long-Term Pulmonary Hemodynamic Effects of Ambrisentan in Pulmonary Arterial Hypertension.
- Impact of endotracheal tube size on preextubation Respiratory variables.
- Marrow cell infusion attenuates vascular remodeling in a murine model of monocrotaline-induced Pulmonary hypertension.
- The right ventricle in sepsis.
- Rottlerin causes Pulmonary edema in vivo: a possible role for PKCdelta.
- Pulmonary hypertension in the intensive care unit: Critical role of the right ventricle.
- Pulmonary arterial hypertension: an overview.
- The nitric oxide/cGMP signaling pathway in Pulmonary hypertension.
- Conversion to bosentan from prostacyclin infusion therapy in Pulmonary arterial hypertension: a pilot study.
- Natriuretic peptides differentially attenuate thrombin-induced barrier dysfunction in Pulmonary microvascular endothelial cells.
- Pulmonary hemodynamic responses to brain natriuretic peptide and sildenafil in patients with Pulmonary arterial hypertension.
- Acute cardiopulmonary hemodynamic effects of brain natriuretic peptide in patients with pulmonary arterial hypertension.
- Synergistic effects of ANP and sildenafil on cGMP levels and amelioration of Acute hypoxic pulmonary hypertension.
- Successful determination of lower inflection point and maximal compliance in a population of patients with Acute respiratory distress syndrome.
- Pulmonary edema caused by inhaled nitric oxide therapy in two patients with Pulmonary hypertension associated with the CREST syndrome.
- Targeted disruption of the gene for natriuretic peptide receptor-A worsens hypoxia-induced cardiac hypertrophy.
- NO: more than just a vasodilator in Lung transplantation.
- Inhaled nitric oxide in ARDS.
- [Treatment of peptic ulcer with ranitidine and cimetidine in a single nocturnal dose].
- [Double-blind study on the long-lasting improvement of physical endurance following oxygen-multistep-therapy].
- Glucocorticoid metabolism in the newborn rat Heart.
- Pulmonary complications from alveolar accumulation of carbonaceous material in a cocaine smoker.
- Multiple cases of life-threatening adenovirus Pneumonia in a mental health care center.
- Stem cells and Pulmonary metamorphosis: new concepts in repair and regeneration.
- Hemodynamics and positive end-expiratory pressure in critically ill patients.
- The natriuretic peptides. Clinical applications in patients with COPD.
- Genetic disruption of atrial natriuretic peptide causes Pulmonary hypertension in normoxic and hypoxic mice.
- Atrial natriuretic peptide accounts for increased cGMP in hypoxia-induced hypertensive rat Lungs.
- The role of endothelin-1 in strain-related susceptibility to develop hypoxic Pulmonary hypertension in rats.
- Exaggerated pulmonary hypertension with monocrotaline in rats susceptible to Chronic mountain sickness.
- The efficacy of inhaled nitric oxide in the treatment of Acute respiratory distress syndrome. An evidence-based medicine approach.
- Right ventricular dysfunction in Chronic obstructive pulmonary disease. Evaluation and management.
- Reduced oxygen tension increases atrial natriuretic peptide release from atrial cardiocytes.
- Prediction of post-extubation work of breathing.
- EDHF contributes to strain-related differences in Pulmonary arterial relaxation in rats.
- Brain natriuretic peptide: possible role in the modulation of hypoxic Pulmonary hypertension.
- Vasoresponsiveness of sarcoidosis-associated Pulmonary hypertension.
- Phytoestrogens restore nitric oxide-mediated relaxation in isolated pulmonary arteries from Chronically hypoxic rats.
- Evidence for the role of p38 MAP kinase in hypoxia-induced Pulmonary vasoconstriction.
- Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced Pulmonary hypertension in rats.
- Atrial natriuretic peptide expression in rats with different Pulmonary hypertensive responses to hypoxia.
- C-type natriuretic peptide expression and Pulmonary vasodilation in hypoxia-adapted rats.
- C-receptor ligand blocks Pulmonary clearance of atrial natriuretic peptide in isolated rat lungs.
- Neutral endopeptidase inhibition attenuates development of hypoxic Pulmonary hypertension in rats.
- Downregulation of pulmonary atrial natriuretic peptide receptors in rats exposed to Chronic hypoxia.
- Cardiopulmonary responses to Chronic hypoxia in transgenic mice that overexpress ANP.
- Differences in Acute hypoxic pulmonary vasoresponsiveness between rat strains: role of endothelium.
- Exaggerated pulmonary hypertensive responses during Chronic hypoxia in mice with gene-targeted reductions in atrial natriuretic peptide.
- Brain natriuretic peptide inhibits hypoxic Pulmonary hypertension in rats.
- Brain natriuretic peptide in Pulmonary arterial hypertension: biomarker and potential therapeutic agent.
- Ambrisentan for the treatment of Pulmonary arterial hypertension.
- Pulmonary hypertension: inhaled nitric oxide, sildenafil and natriuretic peptides.
- Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
- Pulmonary arterial hypertension: new insights and new hope.
- Pulmonary puzzle. An unusual cause of chest pain. Diagnosis: Cor triatriatum sinistrum with secondary unilateral Pulmonary venous hypertension and right lung hypoplasia.
- Cardiac atria are the Primary source of ANP release in hypoxia-adapted rats.
- Tadalafil for the treatment of Pulmonary arterial hypertension.
- Diagnosis and management of Pulmonary arterial hypertension.
Schools
Medical College of Wisconsin
Med College Penn
Ri HospBrown University
Procedures Preformed
- Bronchoscopy
- Thoracentesis
- Ventilation Management
Conditions Treated
- Acidosis
- Acute Pharyngitis
- Alkalosis
- Asthma
- View All
Doctors Specialties
- Critical Care Medicine
- Pulmonology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Brown University -
Medical College of Pennsylvania and Hospital -
Medical College of Wisconsin
Hospital
-
Rhode Island Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Sejal A. Thaker, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mitchell M. Levy, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Brian A. Kimble, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Corina Filip, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samuel K. Evans, MD |
|
|
Michael Van Haute |
|
|
Dr. Andrew C. Stone, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard Renzi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jack A. Elias, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Edmund H. Sears Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sharon I. Rounds, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Kyle R. Brownback, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph V. Meharg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard P. Millman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sidney S. Braman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Walter Donat, MD
This Doctor is OpenDoctor Recommended.
|